The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Established in 1990, this Indian manufacturer employs approximately 3,065 individuals and specializes in developing and manufacturing IP-led niche finished dosage formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from major regulatory authorities, including the US FDA, EU-GMP, Health Canada, and UK MHRA, ensuring compliance with stringent international quality standards. The company operates eight manufacturing units across India, Singapore, Italy, the United States, and Kenya, producing a range of products, including soft gelatin capsules, tablets, and ointments. As a CTD dossier owner and manufacturer, its products are distributed in over 100 countries worldwide.